Jubo Wang
Impact in
- Biological Psychiatry top 10%
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Ubiquitin and proteasome pathways 12
- Protein Degradation and Inhibitors 11
- Natural product bioactivities and synthesis 5
- Histone Deacetylase Inhibitors Research 4
- Oncology 10
- Cancer-related Molecular Pathways 7
- Co-authors
- Jinlei Bian (31 shared papers)Zhiyu Li (38 shared papers)Xi Xu (17 shared papers)Qinglong Guo (5 shared papers)Yifan Feng (2 shared papers)Pengfei Xu (6 shared papers)Libin Wei (2 shared papers)Jie Ren (2 shared papers)
- Journals
- European Journal of Medicinal Chemistry (13 papers)Journal of Medicinal Chemistry (8 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Environmental Toxicology (3 papers)Organic Process Research & Development (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Jubo Wang
52 papers receiving 1.2k citations
Jubo Wang's Hit Papers
Peers
Comparison fields: 5 of 88
- Biological Psychiatry 43
- Cancer Research 191
- Molecular Biology 778
- Oncology 267
- Physiology 48
Countries citing papers authored by Jubo Wang
This map shows the geographic impact of Jubo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jubo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jubo Wang more than expected).
Fields of papers citing papers by Jubo Wang
This network shows the impact of papers produced by Jubo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jubo Wang. The network helps show where Jubo Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jubo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma Hit paper breakdown → | 2021 | 172 |
| 2 | 2018 | 117 | |
| 3 | 2018 | 89 | |
| 4 | 2019 | 80 | |
| 5 | 2020 | 76 | |
| 6 | 2020 | 71 | |
| 7 | 2017 | 45 | |
| 8 | 2021 | 41 | |
| 9 | 2014 | 40 | |
| 10 | 2014 | 39 | |
| 11 | 2021 | 33 | |
| 12 | 2019 | 31 | |
| 13 | 2019 | 28 | |
| 14 | 2017 | 27 | |
| 15 | 2019 | 25 | |
| 16 | 2017 | 24 | |
| 17 | 2023 | 22 | |
| 18 | 2023 | 20 | |
| 19 | 2022 | 18 | |
| 20 | 2024 | 17 |
About Jubo Wang
Jubo Wang is a scholar working on Molecular Biology, Oncology, Pharmacology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (12 papers), Protein Degradation and Inhibitors (11 papers), Flavonoids in Medical Research (7 papers), Cancer-related Molecular Pathways (7 papers), Natural product bioactivities and synthesis (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Prostate Cancer Treatment and Research (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Biological Psychiatry (43 citations), Cancer Research (191 citations), Molecular Biology (778 citations), Oncology (267 citations) and Physiology (48 citations). Jubo Wang has collaborated with scholars based in China and United States. Frequent co-authors include Jinlei Bian, Zhiyu Li, Xi Xu, Qinglong Guo, Yifan Feng, Pengfei Xu, Libin Wei, Jie Ren, Yuening Sun and Jingyue Yao. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Environmental Toxicology and Organic Process Research & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.